| Short Description : | p27 KIP1 Blocking Peptide for STJ501542 is synthetically produced from the N-Term sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen: | N-epitope synthetic peptide corresponding to unique amino acid sequences on human p27 KIP1 protein. |
| Immunogen Region: | N-Term |
| Specificity: | This blocking peptide is recommended for use in combination with p27 KIP1 antibody, STJ501542 |
| Background | cyclin-dependent protein serine/threonine kinase inhibitor activity; plays a role in cell cycle arrest |
Information sourced from Uniprot.org